{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:50Z","timestamp":1792785950421,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T00:00:00Z","timestamp":1524096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Else Kr\u00f6ner-Fresenius-Foundation","award":["2014-A45"],"award-info":[{"award-number":["2014-A45"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,14]]},"DOI":"10.1093\/infdis\/jiy229","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T07:08:56Z","timestamp":1523862536000},"page":"876-885","source":"Crossref","is-referenced-by-count":10,"title":["Identification of Elite Neutralizers With Broad and Potent Neutralizing Activity Against Human Cytomegalovirus (HCMV) in a Population of HCMV-Seropositive Blood Donors"],"prefix":"10.1093","volume":"218","author":[{"given":"Jessica Julia","family":"Falk","sequence":"first","affiliation":[{"name":"Institute for Virology, Ulm University Medical Center, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Winkelmann","sequence":"additional","affiliation":[{"name":"Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood-Transfusion Service Baden-W\u00fcrttemberg\u2013Hessen and University Hospital, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"St\u00f6hr","sequence":"additional","affiliation":[{"name":"Institute for Virology, Ulm University Medical Center, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Alt","sequence":"additional","affiliation":[{"name":"Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Schrezenmeier","sequence":"additional","affiliation":[{"name":"Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood-Transfusion Service Baden-W\u00fcrttemberg\u2013Hessen and University Hospital, Ulm, Germany"},{"name":"Institute for Transfusion Medicine, Ulm University, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalbert","family":"Krawczyk","sequence":"additional","affiliation":[{"name":"Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Lotfi","sequence":"additional","affiliation":[{"name":"Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood-Transfusion Service Baden-W\u00fcrttemberg\u2013Hessen and University Hospital, Ulm, Germany"},{"name":"Institute for Transfusion Medicine, Ulm University, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9282-1783","authenticated-orcid":false,"given":"Christian","family":"Sinzger","sequence":"additional","affiliation":[{"name":"Institute for Virology, Ulm University Medical Center, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,19]]},"reference":[{"key":"key\n\t\t\t\t20180814005626_CIT0001","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(05)66553-1","article-title":"Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials","volume":"365","author":"Hodson","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180814005626_CIT0002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180814005626_CIT0003","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1182\/blood-2009-02-203307","article-title":"Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients","volume":"113","author":"Zhou","year":"2009","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180814005626_CIT0004","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MOH.0000000000000085","article-title":"The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation","volume":"21","author":"Ljungman","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"key\n\t\t\t\t20180814005626_CIT0005","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1093\/cid\/cit629","article-title":"Congenital cytomegalovirus infection: clinical outcome","volume":"57","author":"Boppana","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180814005626_CIT0006","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180814005626_CIT0007","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","article-title":"Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome","volume":"256","author":"Stagno","year":"1986","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180814005626_CIT0008","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1542\/peds.2013-2217","article-title":"Incidence and impact of CMV infection in very low birth weight infants","volume":"133","author":"Turner","year":"2014","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20180814005626_CIT0009","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02392-16","article-title":"Congenital human cytomegalovirus infection and the enigma of maternal immunity","volume":"91","author":"Britt","year":"2017","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180814005626_CIT0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/TP.0b013e318224115e","article-title":"Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations","volume":"92","author":"Planitzer","year":"2011","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180814005626_CIT0011","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00430-012-0229-2","article-title":"Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines","volume":"201","author":"Frenzel","year":"2012","journal-title":"Med Microbiol Immunol"},{"key":"key\n\t\t\t\t20180814005626_CIT0012","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180814005626_CIT0013","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1515\/jpm-2011-0257","article-title":"Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis","volume":"40","author":"Buxmann","year":"2012","journal-title":"J Perinat Med"},{"key":"key\n\t\t\t\t20180814005626_CIT0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/infdis\/jir718","article-title":"Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy\u2013a case-control study of the outcome in children","volume":"205","author":"Nigro","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180814005626_CIT0015","first-page":"273","article-title":"Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis","volume":"12","author":"Bass","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t20180814005626_CIT0016","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJM198710223171703","article-title":"Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients","volume":"317","author":"Snydman","year":"1987","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180814005626_CIT0017","first-page":"17","article-title":"Meta-analysis of CMVIG studies for the prevention and treatment of CMV infection in transplant patients","volume":"28","author":"Wittes","year":"1996","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t20180814005626_CIT0018","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180814005626_CIT0019","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1128\/AAC.00523-15","article-title":"Phase 1 randomized, double-blind, placebo-controlled study of RG7667, an anticytomegalovirus combination monoclonal antibody therapy, in healthy adults","volume":"59","author":"Ishida","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180814005626_CIT0020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01794-16","article-title":"Phase 2 randomized, double-blind, placebo-controlled trial of RG7667, a combination monoclonal antibody, for prevention of cytomegalovirus infection in high-risk kidney transplant recipients","volume":"61","author":"Ishida","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180814005626_CIT0021","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/trf.13906","article-title":"A two-step screening approach for the identification of blood donors with highly and broadly neutralizing capacities against human cytomegalovirus","volume":"57","author":"Falk","year":"2017","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t20180814005626_CIT0022","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2017.07.010","article-title":"Of mice, macaques, and men: broadly neutralizing antibody immunotherapy for HIV-1","volume":"22","author":"Nishimura","year":"2017","journal-title":"Cell Host Microbe"},{"key":"key\n\t\t\t\t20180814005626_CIT0023","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1128\/JVI.00110-09","article-title":"Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm","volume":"83","author":"Simek","year":"2009","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180814005626_CIT0024","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tips.2009.09.005","article-title":"Elucidating the elite: mechanisms of control in HIV-1 infection","volume":"30","author":"O\u2019Connell","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"key\n\t\t\t\t20180814005626_CIT0025","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1241144","article-title":"Antibodies in HIV-1 vaccine development and therapy","volume":"341","author":"Klein","year":"2013","journal-title":"Science"},{"key":"key\n\t\t\t\t20180814005626_CIT0026","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chom.2017.07.013","article-title":"Principles of broad and potent antiviral human antibodies: insights for vaccine design","volume":"22","author":"Crowe","year":"2017","journal-title":"Cell Host Microbe"},{"key":"key\n\t\t\t\t20180814005626_CIT0027","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1016\/j.vaccine.2011.09.056","article-title":"Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180814005626_CIT0028","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/v6031346","article-title":"HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex","volume":"6","author":"Zydek","year":"2014","journal-title":"Viruses"},{"key":"key\n\t\t\t\t20180814005626_CIT0029","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2144\/000114326","article-title":"A permanently growing human endothelial cell line supports productive infection with human cytomegalovirus under conditional cell growth arrest","volume":"59","author":"Lieber","year":"2015","journal-title":"Biotechniques"},{"key":"key\n\t\t\t\t20180814005626_CIT0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/ten.tea.2009.0184","article-title":"Synthetic gene regulation circuits for control of cell expansion","volume":"16","author":"May","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"key\n\t\t\t\t20180814005626_CIT0031","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3181\/00379727-92-22497","article-title":"Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids","volume":"92","author":"Rowe","year":"1956","journal-title":"Proc Soc Exp Biol Med"},{"key":"key\n\t\t\t\t20180814005626_CIT0032","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/IAI.12.3.521-527.1975","article-title":"Candidate cytomegalovirus strain for human vaccination","volume":"12","author":"Plotkin","year":"1975","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180814005626_CIT0033","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-101-4-478","article-title":"Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus","volume":"101","author":"Quinnan","year":"1984","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180814005626_CIT0034","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1099\/vir.0.18856-0","article-title":"Homology between the human cytomegalovirus RL11 gene family and human adenovirus E3 genes","volume":"84","author":"Davison","year":"2003","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20180814005626_CIT0035","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1099\/0022-1317-82-6-1429","article-title":"In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells","volume":"82","author":"Grazia Revello","year":"2001","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20180814005626_CIT0036","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01310761","article-title":"Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells","volume":"117","author":"Waldman","year":"1991","journal-title":"Arch Virol"},{"key":"key\n\t\t\t\t20180814005626_CIT0037","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1099\/0022-1317-80-11-2867","article-title":"Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome","volume":"80","author":"Sinzger","year":"1999","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20180814005626_CIT0038","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jviromet.2016.06.008","article-title":"Generation of a Gaussia luciferase-expressing endotheliotropic cytomegalovirus for screening approaches and mutant analyses","volume":"235","author":"Falk","year":"2016","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20180814005626_CIT0039","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1073\/pnas.1220019110","article-title":"Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody","volume":"110","author":"Krawczyk","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180814005626_CIT0040","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1099\/0022-1317-73-10-2699","article-title":"Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene","volume":"73","author":"Mazeron","year":"1992","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20180814005626_CIT0041","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-62703-601-6_14","article-title":"Applications for a dual fluorescent human cytomegalovirus in the analysis of viral entry","volume":"1064","author":"Sampaio","year":"2013","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t20180814005626_CIT0042","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1113\/JP274819","article-title":"Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approaches","volume":"595","author":"Eigenmann","year":"2017","journal-title":"J Physiol"},{"key":"key\n\t\t\t\t20180814005626_CIT0043","first-page":"CD005129","article-title":"Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients","author":"Hodson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180814005626_CIT0044","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/infdis\/175.3.533","article-title":"The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies","volume":"175","author":"Schoppel","year":"1997","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180814005626_CIT0045","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180814005626_CIT0046","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jmv.1890390303","article-title":"An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus","volume":"39","author":"Kropff","year":"1993","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20180814005626_CIT0047","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMc1405377","article-title":"Hyperimmune globulin to prevent congenital CMV infection","volume":"370","author":"Hamprecht","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180814005626_CIT0048","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/COH.0000000000000150","article-title":"Antibodies for prevention of mother-to-child transmission of HIV-1","volume":"10","author":"Fouda","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"key":"key\n\t\t\t\t20180814005626_CIT0049","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nm.4268","article-title":"Antibody 10-1074 suppresses viremia in HIV-1-infected individuals","volume":"23","author":"Caskey","year":"2017","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180814005626_CIT0050","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J Virol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/6\/876\/25469576\/jiy229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T16:08:32Z","timestamp":1604160512000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/6\/876\/4976609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,4,19]]},"published-print":{"date-parts":[[2018,8,14]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy229","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9,15]]},"published":{"date-parts":[[2018,4,19]]}}}